50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
S&P 500   3,655.04 (-1.03%)
DOW   29,260.81 (-1.11%)
QQQ   274.37 (-0.41%)
AAPL   150.77 (+0.23%)
MSFT   237.45 (-0.20%)
META   136.23 (-2.98%)
GOOGL   98.14 (-0.61%)
AMZN   115.15 (+1.20%)
TSLA   276.01 (+0.25%)
NVDA   122.28 (-2.30%)
NIO   17.62 (-0.11%)
BABA   78.91 (+0.14%)
AMD   66.30 (-2.44%)
T   15.67 (-2.12%)
MU   48.88 (-2.44%)
CGC   2.74 (-3.52%)
F   11.99 (-2.60%)
GE   64.35 (-0.31%)
DIS   98.12 (-1.39%)
AMC   6.83 (-14.52%)
PYPL   84.26 (-3.12%)
PFE   43.83 (-0.57%)
NFLX   224.07 (-1.03%)
S&P 500   3,655.04 (-1.03%)
DOW   29,260.81 (-1.11%)
QQQ   274.37 (-0.41%)
AAPL   150.77 (+0.23%)
MSFT   237.45 (-0.20%)
META   136.23 (-2.98%)
GOOGL   98.14 (-0.61%)
AMZN   115.15 (+1.20%)
TSLA   276.01 (+0.25%)
NVDA   122.28 (-2.30%)
NIO   17.62 (-0.11%)
BABA   78.91 (+0.14%)
AMD   66.30 (-2.44%)
T   15.67 (-2.12%)
MU   48.88 (-2.44%)
CGC   2.74 (-3.52%)
F   11.99 (-2.60%)
GE   64.35 (-0.31%)
DIS   98.12 (-1.39%)
AMC   6.83 (-14.52%)
PYPL   84.26 (-3.12%)
PFE   43.83 (-0.57%)
NFLX   224.07 (-1.03%)
S&P 500   3,655.04 (-1.03%)
DOW   29,260.81 (-1.11%)
QQQ   274.37 (-0.41%)
AAPL   150.77 (+0.23%)
MSFT   237.45 (-0.20%)
META   136.23 (-2.98%)
GOOGL   98.14 (-0.61%)
AMZN   115.15 (+1.20%)
TSLA   276.01 (+0.25%)
NVDA   122.28 (-2.30%)
NIO   17.62 (-0.11%)
BABA   78.91 (+0.14%)
AMD   66.30 (-2.44%)
T   15.67 (-2.12%)
MU   48.88 (-2.44%)
CGC   2.74 (-3.52%)
F   11.99 (-2.60%)
GE   64.35 (-0.31%)
DIS   98.12 (-1.39%)
AMC   6.83 (-14.52%)
PYPL   84.26 (-3.12%)
PFE   43.83 (-0.57%)
NFLX   224.07 (-1.03%)
S&P 500   3,655.04 (-1.03%)
DOW   29,260.81 (-1.11%)
QQQ   274.37 (-0.41%)
AAPL   150.77 (+0.23%)
MSFT   237.45 (-0.20%)
META   136.23 (-2.98%)
GOOGL   98.14 (-0.61%)
AMZN   115.15 (+1.20%)
TSLA   276.01 (+0.25%)
NVDA   122.28 (-2.30%)
NIO   17.62 (-0.11%)
BABA   78.91 (+0.14%)
AMD   66.30 (-2.44%)
T   15.67 (-2.12%)
MU   48.88 (-2.44%)
CGC   2.74 (-3.52%)
F   11.99 (-2.60%)
GE   64.35 (-0.31%)
DIS   98.12 (-1.39%)
AMC   6.83 (-14.52%)
PYPL   84.26 (-3.12%)
PFE   43.83 (-0.57%)
NFLX   224.07 (-1.03%)
OTCMKTS:ERFSF

Eurofins Scientific - ERFSF Stock Forecast, Price & News

$57.02
-2.99 (-4.98%)
(As of 09/26/2022 03:58 PM ET)
Add
Compare
Today's Range
$56.52
▼
$57.02
50-Day Range
$60.01
▼
$83.53
52-Week Range
$56.52
▼
$139.25
Volume
473 shs
Average Volume
563 shs
Market Capitalization
$10.97 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$96.25

Eurofins Scientific MarketRank™ Forecast

Analyst Rating
Hold
2.38 Rating Score
Upside/​Downside
60.4% Upside
$96.25 Price Target
Short Interest
Bearish
0.24% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.05mentions of Eurofins Scientific in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
-2.07%
From $3.87 to $3.79 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.53 out of 5 stars

See Top Rated MarketRank™ Stocks Here
ERFSF stock logo

About Eurofins Scientific (OTCMKTS:ERFSF) Stock

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agro-science, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, and healthcare and cosmetics; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include product compliance and audit, testing, certifications and approvals, inspections, training courses, and digital media and cyber security for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, labelling, law, heavy metals, identity preservation, mealtime, molecular and microbiology, mycotoxins, nutritional analyses, organic containments, packaging/migration, radioactivity, rapidest, sensorsy and consumer research, trainings, veterinary drug residues, and vitamins services. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and technologies services. It operates approximately 900 laboratories in 54 countries. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

Receive ERFSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eurofins Scientific and its competitors with MarketBeat's FREE daily newsletter.

ERFSF Stock News Headlines

September 26, 2022 | finance.yahoo.com
Eurofins divests its Digital Testing business
September 21, 2022 | americanbankingnews.com
Eurofins Scientific SE (OTCMKTS:ERFSF) Sees Significant Growth in Short Interest
September 26, 2022 | CRE Income Fund (Ad)
How To Earn a Tax-Advantaged 10% Dividend Yield
The average annual return of commercial real estate over 20 years is roughly 9.5%, nearly 1% greater than the S&P 500's average annual return of 8.6%. The CRE Income Fund pays an annual 10% dividend yield and is a long-term strategy that returns over $25,000 for every $10,000 invested over the next ten years. pixel
September 15, 2022 | seekingalpha.com
ERFSF Eurofins Scientific SE
September 8, 2022 | finance.yahoo.com
Eurofins Scientific SE (ERF.PA)
September 8, 2022 | finance.yahoo.com
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 August 2022
August 2, 2022 | finance.yahoo.com
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 July 2022
July 27, 2022 | finance.yahoo.com
Eurofins Posts Record Revenues of €3,412m and Overall Results Well in Excess of Its Objectives in H1 2022 and Increases Its Objectives for H2 and FY 2022
September 26, 2022 | CRE Income Fund (Ad)
How To Earn a Tax-Advantaged 10% Dividend Yield
The average annual return of commercial real estate over 20 years is roughly 9.5%, nearly 1% greater than the S&P 500's average annual return of 8.6%. The CRE Income Fund pays an annual 10% dividend yield and is a long-term strategy that returns over $25,000 for every $10,000 invested over the next ten years. pixel
July 1, 2022 | finance.yahoo.com
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 June 2022
June 29, 2022 | finance.yahoo.com
Eurofins DiscoverX Celebrates Shanghai Office Opening
June 28, 2022 | finance.yahoo.com
Eurofins Announces the Success of Its Tender Offers on Its Existing Hybrid Bonds
June 23, 2022 | finance.yahoo.com
Gold Standard Diagnostics, a Eurofins Technologies Company, Announces a PCR Assay for the Detection of the Monkeypox and Orthopox Virus
June 21, 2022 | finance.yahoo.com
Eurofins Successfully Prices New €600m 7-Year 4%-Coupon Senior Unsecured Bonds
June 21, 2022 | finance.yahoo.com
Eurofins Announces Its Intention to Issue New Euro Senior Bonds to Refinance Part of Its Existing Hybrid Bonds
June 10, 2022 | finance.yahoo.com
Eurofins Built Environment Testing Expands AIHA LAP, LLC Certification for Industrial Hygiene Analysis
June 9, 2022 | finance.yahoo.com
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 May 2022
June 2, 2022 | finance.yahoo.com
Eurofins to Acquire Majority Stake in Ajal for Laboratories, to Expand its Food and Pharmaceutical Products Testing Offering in the Kingdom of Saudi Arabia
May 31, 2022 | finance.yahoo.com
Eurofins Enhances Its Clinical and BioPharma Service Offering in Japan with Immune Repertoire Analysis Technology Through the Acquisition of Repertoire Genesis Inc.
May 24, 2022 | finance.yahoo.com
Nation’s PFAS Testing Leader, Eurofins Environment Testing USA, One of the First Commercial Laboratories to receive Accreditation for Draft Method 1633
May 9, 2022 | finance.yahoo.com
PAMM Foundation Outsources Its Laboratory Activities for Pathology and Medical Microbiology ("PAMM") to Eurofins Clinical Diagnostics Netherlands
May 3, 2022 | finance.yahoo.com
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022
May 3, 2022 | finance.yahoo.com
CORRECTING and REPLACING: Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022
April 21, 2022 | finance.yahoo.com
Eurofins Core Business1 Delivers Strong Organic Revenue Growth in Q1 2022, in Line With Its Recently Upgraded Organic Growth2 Objective of 6.5% p.a.
April 4, 2022 | finance.yahoo.com
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 March 2022
March 8, 2022 | finance.yahoo.com
Eurofins Genomics Will Be Conducting Genotyping for up to 5 Million Participants of Our Future Health, UK’s Largest Ever Health Research Programme
March 2, 2022 | finance.yahoo.com
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 28 February 2022
See More Headlines
Receive ERFSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eurofins Scientific and its competitors with MarketBeat's FREE daily newsletter.

ERFSF Company Calendar

Today
9/26/2022
Fiscal Year End
12/31/2022
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Private households
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:ERFSF
Previous Symbol
NASDAQ:ERFSF
CUSIP
N/A
CIK
N/A
Web
www.eurofins.com
Phone
(522) 618-5320
Fax
N/A
Employees
58,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$96.25
High Stock Price Forecast
$110.00
Low Stock Price Forecast
$70.00
Forecasted Upside/Downside
+68.8%
Consensus Rating
Hold
Rating Score (0-4)
2.38
Research Coverage
8 Analysts

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.53
Current Ratio
1.25
Quick Ratio
1.17

Sales & Book Value

Annual Sales
$7.95 billion
Price / Sales
1.38
Cash Flow
$8.73 per share
Price / Cash Flow
6.53
Book Value
$28.78 per share
Price / Book
1.98

Miscellaneous

Outstanding Shares
192,469,000
Free Float
N/A
Market Cap
$10.97 billion
Optionable
Not Optionable
Beta
0.83

Key Executives

  • Dr. Gilles G. Martin Ph.D. (Age 59)
    Chairman & CEO
    Comp: $1.2M
  • Ms. Valerie Hanote (Age 56)
    Exec. Director
    Comp: $340.46k
  • Mr. Laurent Lebras
    Group Admin. & Fin. Director
  • Ms. Sandra Hoeylaerts
    Chief HR Officer
  • Mr. David W. Bryant
    Sr. VP of Strategic Bus. Devel. North America
  • Mr. Gabriel Julia
    Sr. VP of Clinical Diagnostics Europe
  • Dr. Timothy S. Oostdyk
    Exec. VP of BioPharma, Genomics & Agrosciences Services North America
  • Mr. Joachim Reichelt
    Sr. VP of Food & Feed Testing Europe
  • Ms. Yvoine Remy
    Sr. VP of Environment Testing Europe
  • Mr. Rajesh Saigal
    Exec. VP - Asia

Key Competitors

View All Competitors













ERFSF Stock - Frequently Asked Questions

Should I buy or sell Eurofins Scientific stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Eurofins Scientific in the last twelve months. There are currently 5 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" ERFSF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ERFSF, but not buy additional shares or sell existing shares.
View ERFSF analyst ratings or view top-rated stocks.

What is Eurofins Scientific's stock price forecast for 2022?

8 equities research analysts have issued 12 month price targets for Eurofins Scientific's stock. Their ERFSF share price forecasts range from $70.00 to $110.00. On average, they anticipate the company's share price to reach $96.25 in the next twelve months. This suggests a possible upside of 60.4% from the stock's current price.
View analysts price targets for ERFSF or view top-rated stocks among Wall Street analysts.

How have ERFSF shares performed in 2022?

Eurofins Scientific's stock was trading at $127.01 on January 1st, 2022. Since then, ERFSF stock has decreased by 52.8% and is now trading at $60.01.
View the best growth stocks for 2022 here.

Are investors shorting Eurofins Scientific?

Eurofins Scientific saw a increase in short interest in August. As of August 31st, there was short interest totaling 465,800 shares, an increase of 10.1% from the August 15th total of 423,200 shares. Based on an average daily trading volume, of 800 shares, the short-interest ratio is currently 582.3 days.
View Eurofins Scientific's Short Interest.

What is Eurofins Scientific's stock symbol?

Eurofins Scientific trades on the OTCMKTS under the ticker symbol "ERFSF."

How do I buy shares of Eurofins Scientific?

Shares of ERFSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Eurofins Scientific's stock price today?

One share of ERFSF stock can currently be purchased for approximately $60.01.

How much money does Eurofins Scientific make?

Eurofins Scientific (OTCMKTS:ERFSF) has a market capitalization of $11.55 billion and generates $7.95 billion in revenue each year.

How many employees does Eurofins Scientific have?

The company employs 58,000 workers across the globe.

How can I contact Eurofins Scientific?

Eurofins Scientific's mailing address is 23 Val Fleuri, Luxembourg N4, 1526. The official website for the company is www.eurofins.com. The company can be reached via phone at (522) 618-5320 or via email at ir@eurofins.com.

This page (OTCMKTS:ERFSF) was last updated on 9/26/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.